CNS finishes strong
This article was originally published in The Tan Sheet
Executive Summary
Breathe Right nasal strips and FiberChoice supplements drove sales up 27% to $28.4 mil in CNS' fiscal fourth quarter (ended March 31), the firm reports April 28; earnings were $4.1 mil. compared to $0.3 mil. in the prior-year period. Results benefited from increasing consumer demand for Breathe Right strips as well as a longer-than-expected cough/cold season, CEO Marti Morfitt said. Full-year net sales increased 8% to $93.7 mil. while earnings jumped 60% to $13.7 mil. CNS projects first-half sales growth in the 20%-25% range on the strength of two FiberChoice line extensions...